Application of a validated prognostic plasma protein biomarker test for renal decline in type 2 diabetes to type 1 diabetes: the Fremantle Diabetes Study Phase II
These preliminary data suggest that PromarkerD is at least as good a prognostic test for renal decline in type 1 as type 2 diabetes.
Authors
- Scott Bringans (ORCID: https://orcid.org/0000-0003-4760-9377)
- Wendy A. Davis (ORCID: https://orcid.org/0000-0002-5709-8235)
- Tasha S. C. Lumbantobing
- Richard Lipscombe
- Timothy M. E. Davis (ORCID: https://orcid.org/0000-0003-0749-7411)
- James K. C. Lui
- Kirsten E. Peters (ORCID: https://orcid.org/0000-0003-1406-8797)
Institutions
- The University of Melbourne (AU)
- The University of Western Australia (AU)
- Fiona Stanley Hospital (AU)
- Fremantle Hospital (AU)
Publication Details
- Journal
- Clinical Diabetes and Endocrinology
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1186/s40842-024-00191-8
- Citations
- 4
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Medical Research Council
- National Health and Medical Research Council